-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Most Fanconi Anemia Heterozygotes Are Not Aa Increased Cancer Risk: A Genome-First Discovehr Cohort Population Study

Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
Program: Scientific Workshops
Session: Germline Predisposition That Intersects With Lymphoid Malignancies, Solid Tumors, and DNA Repair Pathways
Friday, December 8, 2023, 3:37 PM-4:18 PM

Lisa J. McReynolds, MD, PhD

National Cancer Institute, Rockville, MD

Disclosures: No relevant conflicts of interest to declare.